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Background. Human noroviruses are a highly diverse group of viruses classified into three of the five currently recognised
Norovirus genogroups, and contain numerous genotypes or genetic clusters. Noroviruses are the major aetiological agent of
endemic gastroenteritis in all age groups, as well as the cause of periodic epidemic gastroenteritis. The noroviruses most
commonly associated with outbreaks of gastroenteritis are genogroup II genotype 4 (GII-4) strains. The relationship between
genotypes of noroviruses with their phenotypes and antigenic profile remains poorly understood through an inability to
culture these viruses and the lack of a suitable animal model. Methodology/Principal Findings. Here we describe a study of
the diversity of amino acid sequences of the highly variable P2 region in the major capsid protein, VP1, of the GII-4 human
noroviruses strains using sequence analysis and homology modelling techniques. Conclusions/Significance. Our data
identifies two sites in this region, which show significant amino acid substitutions associated with the appearance of variant
strains responsible for epidemics with major public health impact. Homology modelling studies revealed the exposed nature
of these sites on the capsid surface, providing supportive structural data that these two sites are likely to be associated with
putative variant-specific epitopes. Furthermore, the patterns in the evolution of these viruses at these sites suggests that
noroviruses follow a neutral network pattern of evolution.
Citation: Allen DJ, Gray JJ, Gallimore CI, Xerry J, Iturriza-Go ´mara M (2008) Analysis of Amino Acid Variation in the P2 Domain of the GII-4 Norovirus
VP1 Protein Reveals Putative Variant-Specific Epitopes. PLoS ONE 3(1): e1485. doi:10.1371/journal.pone.0001485
INTRODUCTION
Noroviruses are the predominant aetiological agent of outbreaks of
infectious gastroenteritis, and are typically associated with winter
seasonality. Outbreaks are mainly reported in hospitals and elderly
care homes, but have also been associated with other semi-closed
environments such as schools, restaurants, cruise ships and hotels
[1,2]. Disease caused by these viruses is usually mild and self-
limiting, which generally subsides 24–48 hours after onset.
However, due to their short incubation time, low infectious dose,
efficient transmission and the short duration of protective
immunity, noroviruses impact significantly on public health,
causing significant morbidity in the population and impose a
significant economic burden on national health services [1,3],
Noroviruses are small non-enveloped viruses with a non-
segmented single-stranded, positive sense, RNA genome, which
encodes the viral structural andnon-structural proteins inthree open
reading frames (ORF). ORF1 encodes a polyprotein that is post-
translationally cleaved by the viral protease into the non-structural
proteins including a VPg-like protein, viral protease and an RNA-
dependent RNA polymerase (RdRp). The second open reading
frame, ORF2, encodes the major structural protein VP1, which has
been shown to be organised into distinct domains [4] including a
conserved shell (S) domain which forms the contiguous shell of the
virus, and a protruding (P) domain which extends away from the
capsid.ThisprotrudingdomainisorganisedintoahighlyvariableP2
region which is flanked on either side by more conserved P1-1 and
P1-2 domains. The P2 domain is the hypervariable region of the
capsidandhasbeensuggestedthatthereceptorbindingfunctionand
antigenic properties of the capsid are localised in this region [5,6].
The ORF3 encodes a small basic protein believed to be involved in
the assembly of progeny particles [7].
There is huge genetic diversity among the human noroviruses,
and the populations of viruses co-circulating change between each
norovirus season and within a season [8,9]. The high degree of
variation observed among the noroviruses is caused by two
mechanisms: mutations as a result of the lack of proof reading
associated with RNA replication and by homologous recombina-
tion, principally at the junction between the ORF1 and ORF2,
and also within the ORF2 [10–15].
The classification of noroviruses is based on the sequence analysis
of the gene encoding the capsid, however, it has been shown that
analysis of conserved fragments of the ORF1 and ORF2 also
provides reliable classification, and for molecular epidemiology
purposes, this is a widely used strategy [8,16]. The majority of
human noroviruses are divided between two genogroups (GI and
GII) and at least 15 genetic clusters within these [17]. The most
frequently detected noroviruses associated with outbreaks belong to
genogroup II, and are of genotype 4 (GII-4) [8].
In 2002, a GII-4 norovirus genetic variant spread within
populations around the world causing large epidemics throughout
the year and was characterised by an atypically large number of
outbreaks during the summer and autumn months [18,19]. It is
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the previously circulating noroviruses; however, a number of
conserved point mutations were detected both in the RdRp and
capsid encoding genes, and most notably, a 3 nucleotide (nt)
insertion was seen within the ORF2, localised within the P2
domain. Similarly, another GII-4 variant strain was associated
with an increase in out-of-season infection followed by an
epidemic season in 2006 [20].
In this paper we describe the amino acid (aa) variation observed
in the P2 domain of a number of isolates of GII-4 noroviruses
collected between 1997 and 2006, and which represent GII-4
variant strains circulating over a 9 year period in the UK. The
strains include two epidemiologically significant strains that gave
origin to large epidemics and to out-of-season activity. Potentially
immunologically significant variant-specific epitopes in the P2
domain of the capsid protein VP1 are identified and described
through homology modelling.
METHODS
Clinical Samples
Faecal samples were selected from outbreaks occurring between
1997–2006, that had previously been characterised by PCR as
being caused by GII-4 norovirus strains, which are archived at the
Enteric Virus Unit, Centre for Infections, Health Protection
Agency, London. Samples were prepared as 10% suspensions in
balanced salt solution (Medium 199, Sigma, Dorset, UK) prior to
nucleic acid extraction.
Nucleic Acid Extraction
A total of 250 ml of the 10% sample suspensions was used for
nucleic acid extraction using the guanidium isothiocyanate/silica
method as previously described [21].
Reverse Transcription
Extracted nucleic acid was incubated in the presence of 50 pmol of
poly(T) primer, tris-HCl buffer at pH 8.3, 5 mM MgCl2,1m M
each dNTP and 200U SuperScript III Reverse Transcriptase
(Invitrogen, Paisley, UK). The reverse transcription reaction was
performed at 42uC.
PCR
A region of the ORF2 1521 bp–1524 bp in length and encompass-
ing the N-terminus through to the end of the P2 domain was
amplified using primers ORF1/2-F1 (sense primer, nt position
5039–5057) [59-CTGAGCACGTGGGAGGGCG-39] and P2R2
(antisense primer, nt position 6537–6560) [5-CCTGCACTCAAA-
CAGAACCCTACC-3]. The reaction mix contained 16 reaction
buffer (Invitrogen), 1 mM each dNTP, 2.0 mM MgCl2,2 0p m o lo f
each primer and recombinant Taq polymerase (5U) (Invitrogen).
The thermal cycling conditions used were: 1 cycle of 94uC, 29,
followed by 30 cycles of 94uC, 450/60uC, 450/72uC, 19 400, and a
final extension at 72uC, 109.
Amplicon Purification
Amplicons were purified either from solution using MontageH
PCR Filter Units (Millipore, Watford, UK), or from agarose gels
using GenecleanH Spin Kit (Qbiogene, Cambridge, UK), both
were performed according to manufacturers’ instructions.
Amplicon Sequencing
The purified amplicons were used as a template in sequencing
reactions. In order to sequence the S domain the following primers
were used: ORF1/2-F1 (see above), SpeI-F (sense primer, nt
position 5068–5095) [59-AGCTCACTAGTCTGTGAATGAA-
GATGGC-39] or Mon381 [22]. Primers used for sequencing of
the P2 domain were: P2F (sense primer, nt position 5873–5894)
[59-TGGCAGRTGYACGACTGATGG-39] or P2R2 (see above).
In each sequencing PCR, 10 pmol of primer were used, and
100 fmol of template DNA. All sequencing was performed using
the GenomeLab DTCS – Quick Start Kit (Beckman Coulter,
High Wycombe, UK) according to the manufacturer’s instruc-
tions, and a CEQ8000 automated sequencer (Beckman Coulter).
Sequence Analysis
AA sequence data was deduced from nt data using BioEdit [23], and
were analysed using BioNumerics v3.5 (Applied Maths, Kortrijk,
Belgium). Here, analysis is focused on the P2 domain (aa position
279–406) and P2 domain clusters (P2x: where x can be the cluster
designation) are assigned based on aa positions 296–298 (site A) and
393–395 (site B) as described in Table 1. Clusters were defined by
change of one or more aa residues within site A and/or site B.
Protein Modelling
The software packages YASARA (www.yasara.org) and Deep
View Swiss-PDB Viewer (www.expasy.org/spdbv) were used to
model changes in the P2 domain 3D structure. The previously
published crystal structure of norovirus strain VA387 was used in
the analysis and is available as a PDB file from www.rcsb.org, DOI
10.2210/pdb2obs/pdb [24].
RESULTS
Nucleotide data for 66 P2 domain sequences revealed significant
diversity of up to 20% across this region. Analysis of the sequences
by the neighbour joining method followed by bootstrap analysis
(1000 pseudoreplicates) revealed four genetic lineages defined by
bootstrap values $99%, Figure 1.
Alignment of derived aa sequences revealed 31 hotspots of
variation across the P2 domain (aa positions where $2aa changes
between strains were observed), as well as random point mutations
(Figure 2). Hotspots which resulted in homologous aa substitutions
and werelocated inan unexposedregionofthecapsidstructurewere
deemed unlikely to have a major impact on the antigenic properties
of the viruses. Homologous and/or non-homologous changes at aa
hotspots that coincided with the epidemic waves and were located in
exposed regions of the capsid structure were predicted to have a
significant impact on the antigenic properties of the virus. Six
positions in which significant aa substitutions that would impact on
the biochemical properties and structure of the P2 domain of the
virus were identified: aa positions 296–298 (site A) and 393–395 (site
B) (Figures 2 and 3). All 6 of these positions localise to external points
inthe 3Dstructure of the capsid, and areparts of exposed loops. The
aa sequence changes observed at these 6 positions were then
correlated with the temporal appearance of epidemiologically
significant strains. This analysis identified 13 clusters (P2a-P2m)
based on the aa sequence changes at these six positions (Table 1).
The biochemically significant changes observed at aa sites 296–298
and 393–395 showed a strong association with the emergence of
epidemiologically significant strains.
In addition to the six aa positions identified as sites A and B, a
seventh position, aa 340, was noted to be of interest. This position
is surface-exposed and non-homologous changes are observed
over the time period assessed here. Whilst the aa changes at
position 340 do not consistently coincide with the epidemic waves
as strongly as those at sites A and B, there is one change that is
noteworthy. Synchronised with the 2002 epidemic, an aa
Putative Epitopes in GII-4 NoV
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binding RGD motif, sterically close to both the binding pocket
proposed by Tan et al [25] and the histo-blood group antigen
(HBGA)-binding site identified by Cao et al [24]. This motif was
detected from 2002–2003, but only in GII-4 strains and not again
afterwards.
In order to understand the impact of the cluster-defining aa
substitutions observed at sites A and B, three sequences, one
representing strains co-circulating before the 2002 epidemic (P2
domain cluster a [P2a]), a second representing the 2002 epidemic
strain (P2e), and a third representing the 2006 epidemic strain (P2j)
were chosen for homology modelling using as a template the
recently described P domain crystal structure of the GII-4
norovirus strain VA387 [24].
Firstly, an aa alignment between P2a, P2e, P2j and VA387 was
made (Figure 4). All four sequences shared a high degree of
similarity, and strains VA387 and P2a were found to be most closely
related as both strains were co-temporal and both lacked the
insertion at position 393. Regions of the P1 domain involved in
dimerisation (aa positions 454–463) were found to be conserved in
the alignment with VA387, and the variable regions identified in the
P2 domain showed consistent variation when VA387 was aligned
with samples representing clusters P2a, P2e and P2j (Figure 4).
The aa changes at sites A and B of P2a, P2e and P2j were in
turn modelled onto the crystalline structure of strain VA387
(Figures 5 and 6). Molecular surface modelling at aa sites A and B
revealed substantial changes in the surface shape and surface area
of VP1 at both positions. The most significant change between P2a
and P2e was the change in surface shape at site B, which was
maintained between P2e and P2j, whereas site A appeared to vary
substantially in shape between all three clusters (Figure 5). Analysis
of the electrostatic surface (Figure 6) showed that at site A the
surface was greater for P2a when compared with P2e. Therefore,
major changes both in structure and electrostatic charges were
detected between P2a (pre-2002) and P2e (2002), and P2e (2002)
and P2j (2006), but less pronounced between P2a (pre-2002) and
P2j (2006) (Figures 5 and 6). Both molecular and electrostatic
surfaces maintained a constant structure in all three clusters in
regions of the P domain associated with homodimerisation.
DISCUSSION
RNA viruses show a high degree of genetic variability and the pool
of variants results in a mechanism of virus evolution and survival
[26]. Variation at the genome level can result in silent mutations,
mutations that are expressed as homologous aa substitutions, or as
aa substitutions that change the properties of virus binding or the
immunogenicity of virus epitopes and lead to the generation of
virus strains with altered tropism or antibody-escape mutants,
respectively.
Previous studies have analysed the diversity among GII-4
noroviruses through sequence analysis across the S domain, and
shown that the accumulation of point mutations leads to the
emergence of variant strains which at times co-circulate, but
periodically a variant is selected and is associated with widespread
epidemicsandout-of-seasonactivity[8,18,19].Ithasbeenpostulated
that the success of these variants was due to either immune evasion
or changes in receptor binding. As discussed, this is unlikely to be
associated with changes in the S domain as this region is one of the
most conserved regions of the norovirus capsid and it is not exposed
and is therefore unlikely to contain immunologically relevant
epitopes. The high mutation rate and exposed structure of the P2
domain of the capsid protein has led to the assumption that receptor
binding sites and key antigenic determinants are localised in this
region [24,25]. In this paper we assess the diversity of GII-4
norovirus strains at the hypervariable P2 domain suspected to be
responsible for virus attachment and immune reactivity, at the
nucleotide sequence level, deduced aa level and homology analysis
through comparison with the crystal structure of a GII-4 P domain,
and related these changes to the emergence of epidemic strains.
The analysis presented in this paper showed a high level of
diversity in the P2 domain, far greater than that identified in the S
domain, and the identification of numerous hotspots for mutation
(Figure 2). Detailed analysis of the substitutions at these hotspots
Table 1. Distribution of P2 domain clusters characterised by changes of one or more residue within the motifs defined as site A and
site B, each composed of 3 aa positions
..................................................................................................................................................
Motif Year
P2 Domain
Cluster Epidemiological Variant
Number of
Strains
Site A Site B 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
SHD N-N 11 0 3 P2a pre-2002 14
SHD S-N 12 P2b 3
THD NSN 11 P2c 2002 epidemic through to 2006 2
THN NGT 24 P2d 6
TRT STA 1 P2e 1
TRT SST 11P2f 2
SRN STT 1 P2g 1
TQN STT 10 4 2 P2h 16
TQN NTT 9 P2i 9
TQE STT 9 P2j 2006 epidemic 9
TQE NTT 1 P2k 1
TQE SAT 1 P2l 1
TQH STT 1 P2m 1
n=6 6
Numbers indicate the number of sequences associated with each P2 domain cluster in each year. Each sequence represents a different outbreak.
doi:10.1371/journal.pone.0001485.t001
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PLoS ONE | www.plosone.org 3 January 2008 | Issue 1 | e1485and their mapping onto the crystal structure of VA387 revealed
two sites, both three aa residues in length, one located near the N-
terminus and one near the and C-terminus of the P2 domain
(Figure 2 and Table 1). Both sites were located in exposed loops of
the P2 domain, and may play an important role in immune
responses. These two sites changed in a temporal fashion and
significant changes at these sites coincided with the appearance of
epidemiologically significant virus strains in the population which
resulted in epidemics of gastroenteritis. In addition, it was
observed that site A is in close proximity to the HBGA-binding
site in the 3D structure of the P domain of the capsid [24].
Conformational changes at this site may also have an impact on
binding of these viruses to host cells.
Random neutral drift of aa sequences in proteins has long been
established [27], and mapping of such changes has been described
using neutral networks [28]. A neutral network can be regarded as
Figure 1. Phylogenetic tree based on nt data showing 66 GII-4 norovirus sequences used in this study. Values indicate significant bootstrap values
(1000 pseudoreplicates) that define lineages. Genetic lineages marked on the right (I–IV). Dates indicate the year of isolation
doi:10.1371/journal.pone.0001485.g001
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PLoS ONE | www.plosone.org 4 January 2008 | Issue 1 | e1485Figure 2. Clustal W alignment of amino acid sequences representing each P2 domain cluster. Deduced amino acid data for 27 of the 66 strains
analysed were aligned to represent the 13 P2 domain clusters. Actual numbers of sequences found at each P2 domain cluster are shown in Table 1. *
indicates a hotspot ($2aa changes at the site), and labelled arrows indicate sites putatively associated with antigenic change and cluster transition.
doi:10.1371/journal.pone.0001485.g002
Figure 3. Conformational P domain (strain VA387) showing positions of potentially significant variation hotspots. Hotspots identified as
significant amino acid changes were mapped onto the crystal structure of strain VA387. Sites A and B are coloured magenta. RGD motif associated
with the binding pocket described by Tan et al [25] is coloured yellow. The RGD motif associated with the epidemic in 2002 described in this paper is
coloured gray. The sugar molecule indicates the position of the putative binding site proposed by Cao et al [24].
doi:10.1371/journal.pone.0001485.g003
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PLoS ONE | www.plosone.org 5 January 2008 | Issue 1 | e1485Figure 4. Alignment comparing VA387 strain used in homology modelling with sequences representing epidemiologically significant clusters.
Deduced amino acid sequences representing P2 domain clusters P2a, P2e and P2j were aligned with strain VA387 which was used in homology
modelling. Key in the figure indicates domains of the VP1 protein. Shaded box indicates the conserved a-helix involved in dimerisation.
doi:10.1371/journal.pone.0001485.g004
Figure 5. Homology model showing changes in molecular surface. Changes at site A and B (orange) were modelled onto the crystal structure of
VA387, and the molecular surface calculated using default settings in Deep View Swiss PDB Viewer program. Significant changes in the shape of the
molecular surface were observed at site B between P2 domain clusters P2a and P2e, which was maintained between clusters P2e and P2j. Site A
changed more significantly between clusters P2e and P2j than between P2a and P2e.
doi:10.1371/journal.pone.0001485.g005
Putative Epitopes in GII-4 NoV
PLoS ONE | www.plosone.org 6 January 2008 | Issue 1 | e1485Figure 6. Homology Model showing changes in electrostatic surface. Changes at site A and B were modelled onto the crystal structure of VA387
and the electrostatic surface calculated using default settings in Deep View Swiss PDB Viewer. Significant changes in the electrostatic surface were
observed between clusters P2a and P2e, but not between P2a and P2j.
doi:10.1371/journal.pone.0001485.g006
Figure 7. Representation of genotype-to-phenotype mapping of the drift of virus clusters through connected neutral networks. Each coloured box
represents a neutral network, where although a number of different amino acid sequences exist in the sequence space, the resulting conformational
protein ishomologous within each network,but distinct fromeveryother network.(a) Twoclusters (blue dots) wereidentifiedcomprisingsequencespre-
2002 epidemic (Table 1), and share epitope shape at sites A and B, although differ in primary amino acid sequence. (b) Acquisition of point mutations at
sites A and B around 2001–2002 that are sufficient to alter the conformational structure of VP1 occur concurrently, and thus this virus (orange dot) moves
fromone neutral network tooccupy sequencespace ona different neutral network. Change in conformational structure of putative epitope sites A and B
following transition toa different neutral network gives these viruses a selective advantage as theyare able toevade existing immunity in the population,
thus resulting in the epidemic of gastroenteritis observed in 2002, as antibody-driven selection among the virus populations favours those on this,
different,neutralnetwork.(c) Followingselection,thevirusdriftsthroughthesequencespaceoftheneutralnetwork,acquiringhomologoussubstitutions
in the primary amino acid sequence. (d) Acquisition of point mutations around 2005–2006 that connect the virus to a third neutral network thenputs this
virus at a selective advantage as it can evade existing immunity. Again, the result in epidemic gastroenteritis as observed in 2006 as selection drives
transition from one neutral network to another. (e) The virus now drifts neutrally through the sequence space of this neutral network.
doi:10.1371/journal.pone.0001485.g007
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PLoS ONE | www.plosone.org 7 January 2008 | Issue 1 | e1485a group of genotypes that are linked by point mutations which are
selectively neutral. This results in grouping of virus strains by
epitope structure rather than sequence diversity.
The aa sites A and B showed both significant and neutral aa
changes. Periodically, significant aa substitutions occurred concom-
itantly at aa sites A and B, and this resulted in both cluster transition
(progression from one defined cluster to another through aa changes
at site A and/or site B) and resulting in the appearance of
epidemiologically significant virus strains (Table 1). In this context,
GII-4 norovirus strains circulating before 2002 constituted a neutral
network of viruses which were antigenically indistinguishable from
each other, although there was significant sequence diversity among
them. Mutations, as proposed in this paper, at sites A and B resulted
inconformationalchangesthatalteredtheantigenicpropertiesofthe
viruses, and distinguished them from those circulating in previous
years, leading to the emergence of a major epidemic [18] possibly
due to lack of herd immunity. Genetic drift continued to generate
mutationsand increasediversityamongthestrainscirculatingduring
and after this epidemic constituting another neutral network of
viruses which although diverse at the nt and aa level, were
antigenically equivalent, until significant changes occurred again at
sites A and B which coincided with another epidemic wave that lead
subsequently to a third neutral network (Figure 7). It has recently
been shown that the characteristic punctuated appearance of
antigenically novel strains of influenza A virus can be described by
neutral networks [29] in a similar way to that described for GII-4
noroviruses here.
Homology modelling using the recently published crystal
structure of GII-4 strain VA387 [24] revealed structural data
which supported our conclusion that sites A and B together act as
variant-specific epitopes. Both sites localised to surface exposed
loop structures (Figure 3), and at both sites aa mutations associated
with cluster transitions were found to also be linked to substantial
variation in the molecular and electrostatic surface of the protein
(Figure 5 and Figure 6). The conformational changes observed at
aa positions 297, 298, 394 and 395 coincided with the appearance
of an epidemiologically significant variant and antigenic cluster
transition (Table 1 and Table 2). Changes at these positions create
a substantial change in bulk and biochemical properties among the
residues at their respective site (Table 2). These structural and
electrostatic changes may be sufficiently prominent to obscure the
site from recognition by existing antibodies (Figure 5 and Figure 6),
thus permitting the virus to escape the host pre-existing immunity.
A study similar to that presented here, looking at the sequence
diversityamongGII-4norovirusesandinsilicoanalysisofthechanges
observed, was published recently by Siebenga et al [9], however the
interpretation of the data by Siebenga et al is not in agreement with
the data presented here. The study of Siebenga et al concludes that
five individual aa positions spread across the entire P domain
displayed consistent changes which were informative for distinguish-
ing new epidemic variants [9]. In contrast, we predict that only sites
within theP2domainthatare exposed intheconformational protein
will affect the immunogenicity of the virus. There are a number of
significant differences between the two studies which may have
resulted in the conflicting interpretations of essentially equivalent
data sets. Firstly, Siebenga et al choose to model the aa changes they
have observed onto the crystal structure of Norwalk virus [4],
whereas our homology modelling study was performed using the
recently described crystal structure for the virus VA387 [24].
Norwalk virus is a GI virus and has a shorter capsid protein,
including a shorter P2 domain, whereas VA387 is a GII-4 norovirus,
and therefore VA387 is an accurate model for the sequence data
used in analyses involving GII-4 strains. Secondly, the association of
the sequence data with epidemiological information is an important
part of the analysis in both papers. In this paper, we show that the
changes at 6 specific aa positions occur by a process of drift and that
significant changes at these positions coincide with epidemics
observed across Europe in 2002 [18] and 2006 [J Harris, personal
communication; 20], and furthermore, the trend is observed
continuously for all isolates from all years analysed. In contrast,
the study of Siebenga et al identifies 2004 as an epidemic year, and
although equivalent variant strains were circulating in the UK in
2004, such an epidemic was not observed in the UK or throughout
Europe [J Harris, personal communication]. Furthermore, their
analysis specifically excludes sequence data from 2006 epidemic
strains. Finally, Siebenga et al base their conclusions on sequence
analysis and homology modelling alone, however details of the
effects the changes at the 5 positions identified in their paper would
have on the conformation of VP1 are not addressed in detail. In this
study, we introduce associations between the reported epidemiology
of noroviruses, the sequence diversity observed among temporally
separated viruses, and link this with these biochemical properties of
the capsid protein.
This analysis presented in this paper has predicted sites within
the P2 domain that may be immunologically significant but it
remains to be proven that mutation at these sites result in
antibody-escape mutants. Following the in silico identification of
putative epitopes here, work is currently underway to assess the
functionality of these sites in vitro.
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Table 2. Key mutations in sites A and B
......................................................................
Cluster
P2a P2e P2j
Site A 297 Amino Acid HR Q
Properties Basic Basic Polar
Size Change Increase Decrease
298 Amino Acid DT E
Properties Acid Polar Acid
Size Change Increase Decrease
Site B 394 Amino Acid -T T
Properties Polar Polar
Size Change Increase None
395 Amino Acid NA T
Properties Polar Neutral Polar
Size Change Decrease Increase
Characteristics in bold text indicate a change from previous cluster, i.e. P2a R
P2e, or, P2e R P2j. ‘-’ indicates no residue present, and was the site of the
subsequent 3nt insertion.
doi:10.1371/journal.pone.0001485.t002
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